A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Clinical trial NCT07284849 · RECRUITING
Trial details
- NCT number
- NCT07284849
- Sponsor
- Incyte Corporation
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-05
- Primary completion
- 2028-12-29
- Enrollment
- 700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.